Download PDFPDF

Association between statin use and herpes zoster: systematic review and meta-analysis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Herpes zoster reactivation and ststin use
    • Rodney P Jones, Statistical advisor Healthcare Analysis & Forecasting

    Dear Authors,
    I have read your study with interest. May I raise an interesting point you may wish to investigate? I have been researching curious international patterns of on/off switching in deaths and medical admissions. When looking at Australian data I noted that switch-on seemed to correspond with the reported incidence of GP consultation for Herpes Zoster, i.e. switch-on may have reactivated Herpes infections. More details of this research are available at - I hope that this is useful to your research.

    Conflict of Interest:
    None declared.